202 related articles for article (PubMed ID: 11553536)
1. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.
Ogunniyi AD; Woodrow MC; Poolman JT; Paton JC
Infect Immun; 2001 Oct; 69(10):5997-6003. PubMed ID: 11553536
[TBL] [Abstract][Full Text] [Related]
2. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
Ogunniyi AD; Folland RL; Briles DE; Hollingshead SK; Paton JC
Infect Immun; 2000 May; 68(5):3028-33. PubMed ID: 10769009
[TBL] [Abstract][Full Text] [Related]
3. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
[TBL] [Abstract][Full Text] [Related]
4. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.
Ogunniyi AD; Grabowicz M; Briles DE; Cook J; Paton JC
Infect Immun; 2007 Jan; 75(1):350-7. PubMed ID: 17088353
[TBL] [Abstract][Full Text] [Related]
5. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
[TBL] [Abstract][Full Text] [Related]
6. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
Mann B; Thornton J; Heath R; Wade KR; Tweten RK; Gao G; El Kasmi K; Jordan JB; Mitrea DM; Kriwacki R; Maisonneuve J; Alderson M; Tuomanen EI
J Infect Dis; 2014 Apr; 209(7):1116-25. PubMed ID: 24041791
[TBL] [Abstract][Full Text] [Related]
7. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
9. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
[TBL] [Abstract][Full Text] [Related]
11. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
12. Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.
Verhoeven D; Perry S; Pichichero ME
Clin Vaccine Immunol; 2014 Aug; 21(8):1037-45. PubMed ID: 24850621
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.
Hermand P; Vandercammen A; Mertens E; Di Paolo E; Verlant V; Denoël P; Godfroid F
Hum Vaccin Immunother; 2017 Jan; 13(1):220-228. PubMed ID: 27768518
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae.
Lock RA; Hansman D; Paton JC
Microb Pathog; 1992 Feb; 12(2):137-43. PubMed ID: 1350045
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
16. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
Ferreira DM; Arêas AP; Darrieux M; Leite LC; Miyaji EN
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
[TBL] [Abstract][Full Text] [Related]
18. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
Ricci S; Janulczyk R; Gerlini A; Braione V; Colomba L; Iannelli F; Chiavolini D; Oggioni MR; Björck L; Pozzi G
Vaccine; 2011 Oct; 29(46):8241-9. PubMed ID: 21911026
[TBL] [Abstract][Full Text] [Related]
19. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.
Zhang Q; Choo S; Finn A
Infect Immun; 2002 Oct; 70(10):5363-9. PubMed ID: 12228260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
